AAAAAA
Results:
1-7
|
Results: 7
Authors:
Corera, AT
Do-Rego, JC
Costentin, J
Bonnet, JJ
Citation: At. Corera et al., Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes, NEUROSCI RE, 39(3), 2001, pp. 319-325
Authors:
Syringas, M
Janin, F
Giros, B
Costentin, J
Bonnet, JJ
Citation: M. Syringas et al., Involvement of the NH2 terminal domain of catecholamine transporters in the Na+ and Cl--dependence of a [H-3]-dopamine uptake, BR J PHARM, 133(3), 2001, pp. 387-394
Authors:
Corera, AT
Costentin, J
Bonnet, JJ
Citation: At. Corera et al., Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements, N-S ARCH PH, 362(3), 2000, pp. 213-221
Authors:
Syringas, M
Janin, F
Mezghanni, S
Giros, B
Costentin, J
Bonnet, JJ
Citation: M. Syringas et al., Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na+ - and Cl- -dependence of dopamine transport, MOLEC PHARM, 58(6), 2000, pp. 1404-1411
Authors:
Do-Rego, JC
Hue, H
Costentin, J
Bonnet, JJ
Citation: Jc. Do-rego et al., Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine, J NEUROCHEM, 72(1), 1999, pp. 396-404
Authors:
Do Rego, JC
Syringas, M
Leblond, B
Costentin, J
Bonnet, JJ
Citation: Jc. Do Rego et al., Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat, BR J PHARM, 128(1), 1999, pp. 51-60
Authors:
Cleren, C
Vilpoux, C
Dourmap, N
Bonnet, JJ
Costentin, J
Citation: C. Cleren et al., Acute interactions between L-DOPA and the neurotoxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine in mice, BRAIN RES, 830(2), 1999, pp. 314-319
Risultati:
1-7
|